IU Ventures portfolio company Diagnotes makes a positive difference during the COVID-19 outbreak

By Teri Willey, executive director of IU Ventures and fund manager of IU Philanthropic Venture Fund LLC

Several health systems in Indiana, including IU Health, are using the sophisticated health care collaboration and telehealth features of Diagnotes to facilitate the screening and treatment of patients and reduce the risk of spreading the novel coronavirus or exposing high-risk groups.

With Diagnotes, they are able to streamline infectious disease workflows, decrease the number of patients with non-life-threatening COVID-19 symptoms coming to the hospital and keep personal protective equipment for those in greatest need. These actions offer the potential to decrease the number of people who get the virus, slow the infection rate, and avoid overtaxing hospitals and care teams.

At 7 p.m. Wednesday, April 15, IU Kelly School of Business of Medicine Program, the Regenstrief Institute and the Society of Physician Entrepreneurs will host a webinar to share strategies and tools for critical care team coordination and patient engagement during this COVID-19 crisis and beyond.

IU Ventures, through investments from the Innovate Indiana Fund and, more recently, the Indiana Philanthropic Venture Fund, has been an early investor and constant supporter of this innovative company and its determined team.